12th June 2019
Venue: Royal Society of Medicine
One Wimpole Street, the home of the Royal Society of Medicine, is based at 1 Wimpole Street,
London, W1G 0AE
Educational Objectives
1. Diagnosis and Management of Neuroendocrine tumours.
2. To review current role of Radionuclide imaging and tracers: Indications, Advantages, Limitations, Normal Variants and Pitfalls.
3. To review current role of Radionuclide therapy: indications, contraindications, side effects and complications.
4. To support individuals and departments in introducing PRRT service.
Summary
The masterclass is dedicated to the use of radionuclide molecular imaging and therapy in neuroendocrine tumours (NETs). Currently both SPECT and PET tracers are used in used in the management of NETs. The rationale and clinical use of these tracers with their advantages and limitations will be reviewed with classical examples. Peptide Receptor Radionuclide Peptide therapy (PRRT) is used in the treatment of patients with NETs. Patient selection, preparation, and procedure will be discussed in detail with classical cases followed by question and answers related to PRRT in routine practice. Further there will be a Practical demonstration video of the procedure and an interactive quiz.
Organisers
- Dr Shaunak Navalkissoor
- Dr Gopinath Gnanasegaran.
- Prof Martyn Caplin
- Dr Christos Toumpanakis
Faculty
- Ann Marie Quigley
- Lovelyn Colcol
- Bruno Ferreira
- Martyn Caplin
- Christos Toumpanakis
- Neil Davis
- Danny McCool
- Noel Santillan
- Fred Wickham
- Richard Meades
- Gopinath Gnanasegaran
- Shaunak Navalkissoor
- Ivy Vito